[go: up one dir, main page]

TW200848371A - Method of recovering Cd-112 isotope - Google Patents

Method of recovering Cd-112 isotope Download PDF

Info

Publication number
TW200848371A
TW200848371A TW96121583A TW96121583A TW200848371A TW 200848371 A TW200848371 A TW 200848371A TW 96121583 A TW96121583 A TW 96121583A TW 96121583 A TW96121583 A TW 96121583A TW 200848371 A TW200848371 A TW 200848371A
Authority
TW
Taiwan
Prior art keywords
cadmium
solution
isotope
recovering
precipitate
Prior art date
Application number
TW96121583A
Other languages
Chinese (zh)
Other versions
TWI342867B (en
Inventor
Wu-Zhi Lin
Song-Yun Tang
Original Assignee
Atomic Energy Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atomic Energy Council filed Critical Atomic Energy Council
Priority to TW96121583A priority Critical patent/TW200848371A/en
Publication of TW200848371A publication Critical patent/TW200848371A/en
Application granted granted Critical
Publication of TWI342867B publication Critical patent/TWI342867B/zh

Links

Landscapes

  • Manufacture And Refinement Of Metals (AREA)

Abstract

The present invention is a method of recovering Cd-112 isotope to recover the isotope for recycling use. The method includes reacting a chemical separation media or an electroplating fluid residue including Cd-112 target with hydroxides to produce cadmium hydroxide precipitate; filtering and rinsing the precipitate to recover Cd-112 isotope; calcining the recovered Cd-112 isotope or dissolving the recovered Cd-112 isotope by sodium cyanide and an alkaline solution to form a solid cadmium oxide or an electroplating fluid including Cd-112 target, respectively, which can be used as a contrast media for imaging human organs for medical diagnosis.

Description

200848371 九、發明說明: 【發明所屬之技術領域】 本發明係提供一種回收鎘-112同位素之方法,特 別是本發明係將鎘-112靶材之化學分離液或電鍍液之 剩液藉由與氫氧化物反應使生成氫氧化鎘沉澱物,再 經由過濾漂洗回收鎘-112同位素。 【先前技術】 銦-111放射性同.位素之核子特性係捕捉電子放出 兩個加馬射線特性能譜,由於其半衰期短且能量適中 己廣泛應用於核醫單光子放射電腦斷層掃描(Single Photon Emission Computerized Tomography, SPECT ) 診斷人體器t病變與生理功能研究。 銦-111 之標幟化合物如:inInC13,lnIn-bleomysin 及mIn-DTPA (奥克肽哼)可用於鑑定器官局部腫瘤, 而inIn-Oxine脂溶性錯化合物可標幟於白血球進行膿 腫之造影及診斷炎症等病灶,而1πΙη與單株抗體、血 小板、球蛋白或巨大分子yt-PA ( recombinant tissue plasminogen activator)及 Fab、(Fab')2 (immunoglobulin fragments)等形成之錯化合物則為最新發展具有極佳 應用潛力之造影劑,可掃描出心肌梗塞與血栓之正確 位置及進行凝血酵素與腎功能等相關生理研究。 銦-111同位素之主要生產途徑有112Cd(p,2n)、 inCd(p,n)、natCd(p,xn)、110Cd(d,n)及 109Ag(a,2n)等, 5 200848371 其中以第一種方式利用高豐度濃縮112Cd(970/〇)固體靶 於適當靶厚(〜ΙΟΟμηι)及質子束能量卜22MeV)條件下 可獲得luIn最大產率。 於核醫製藥中心,在迴旋加速器製作核醫藥物奥 克肽噚(銦-111),我國因無法產製類似之同位素,每年 生產核醫藥物奥克肽噚(銦-1U),所需濃縮鎘-112同位 素、’,需抑賴進口,且獲得不易。故,一般習用者係 無法符合使用者於實際使用時之所需。 【發明内容】 本發明之主要目的係在於提供一可節省原料費用 =降低成本之回收鎘_112同位素之方法,而且回收率 高,得到純度高之鎘-112同位素。 為達上述之目的,本發明係提供一回收鎘_112同 位素之方法,係將一鎘-112靶材電鍍液之剩液中加入 一硫化物溶液,使其產生一硫化鎘沉澱物,再利用一 鹽酸將該硫化鎘沉澱物溶解形成一氣化鎘溶液,接著 加入氫氧化物溶液混合產生一氫氧化鎘沉殿物,最 後將該氫氧化鎘沉澱物進行過濾及漂洗以回收鎘_112 同位素。 另,本發明亦可先將一鎘-112靶材化學分離液與 一溴化鎘溶液混合形成一混合液,再取一氫氧化物溶 液加入該混合液中混合攪拌產生一氫氧化鎘沉澱物, 最後將該氫氧化鎘沉澱物經由過濾及漂洗以回收编 200848371 • 112同位素。 【實施方式】 請參閱『第1及第2圖』所示,係為本發明之第 一實施例流程示意圖及本發明之第二實施例流程示意 圖。如圖所示:本發明係為一種回收鎘“12同位素之 方法’可由録·112㈣㈣液之剩液或鑛·112乾材化 學分離液回收錯_112同位素,其中,利用鑛·112乾材 電鍍液之剩液進行回收之方法係至少包括下列步驟: 步驟(A 1 )產生硫化鎘沉殿物工工··將一硫化 物溶液加入一鎘_112靶材電鍍液之剩液中產生一硫化 録沉㈣’其中,該硫化物溶液係可為硫化納溶液、 …π步驟(B 1 )形成氣钱溶液} 2 :將該硫化録 沉澱物加入一鹽酸溶解以形成一氣化鎘溶液。 步驟(C 1 )產生氩氧化鎘沉澱物工3 :將該氣 =鎘溶液加入一意氧化物溶液混合產生一氫氧化鎘沉 澱物,其中,亥氫氧化物溶液係可為氫氧化卸溶液或 是氫氧化鈉溶液。 步驟(D 1 )回收鎘_112同位素工4 :將該氫氧 化鑛沉澱物移入半自動化真空過滤系統’進作過渡及 漂洗以回收鎘-112同位素。 另本發明亦h供利用錫_112 |&材化學分離液進 行回收之方法,係至少包括下列步驟: 200848371 步驟(A 2 )形成混合液2 1 :將鎘-112靶材化 學分離液與溴化鎘溶液混合形成一混合液。 步驟(B 2 )產生氫氧化鎘沉澱物2 2 ··取一氫 氧化物溶液加入上述混合液中混合攪拌,使其產生一 氫氧化鎘沉澱物,其中,該氫氧化物溶液係可為氫氧 化鉀溶液或是氫氧化鈉溶液。 步驟(C 2 )形成鎘-112同位素2 3 :將該氫氧 化鎘沉殿物移入半自動化真空過濾、系統,進行過遽及 》示洗以回收鑛j -112同位素。 從上述兩種方法所回收之鑛-112同位素係可經鍛 燒成為一固態氧化鑛,或利用氰化物溶液與驗性溶液 溶解形成一鎘-112靶材電鍍液,該鎘-112同位素之回 收率可達98%以上,純度亦可達99%左右,且易儲存。 綜上所述,本發明之回收鎘_112同位素之方法, 係回收再循環使用鎘-112同位素,使其回收率及純度 達98%以上,亦可節省採購原料費用及降低核醫製藥 成本,進而使本發明之産生能更進步、更實用、更符 δ使用者之所需,確已符合發明專利申請之要件。 惟以上所述者,僅為本發明之較佳實施例而已, 當不能以此限定本發明實施之範圍;故,凡依本發明 申請專利範圍及發明說明書内容所作之簡單的等效變 化與修飾,皆應仍屬本發明專利涵蓋之範圍内。 200848371 【圖式簡單說明】 第1圖 ,係本發明之第一實施例流程示意圖。 第2圖,係本發明之第二實施例流程示意圖。 【主要元件符號說明】 步驟(A 1 )〜(D 1 ) 1 1〜1 4 步驟(A2)〜(C2)21〜23200848371 IX. Description of the Invention: [Technical Field] The present invention provides a method for recovering cadmium-112 isotope, and in particular, the present invention uses a chemical separation liquid or a plating solution of a cadmium-112 target to The hydroxide reaction produces a cadmium hydroxide precipitate which is then recovered by filtration to recover the cadmium-112 isotope. [Prior Art] The nucleon characteristic of indium-111 radioactive isotopes is the capture of electrons to release two additional gamma ray performance spectra. Due to its short half-life and moderate energy, it has been widely used in nuclear medicine single photon emission computed tomography (Single Photon). Emission Computerized Tomography, SPECT ) Diagnose t disease and physiological function of human body. Indium-111 flag compounds such as: inInC13, lnIn-bleomysin and mIn-DTPA (Octopeptide) can be used to identify local tumors, while inIn-Oxine fat-soluble compounds can be labeled in white blood cells for angiography and diagnosis of abscesses. Inflammation and other lesions, and 1πΙη and the monogenic antibodies, platelets, globulins or yt-PA (recommended tissue plasminogen activator) and Fab, (Fab') 2 (immunoglobulin fragments) and other compounds are the latest developments The contrast agent with good application potential can scan the correct position of myocardial infarction and thrombus and carry out related physiological research on thrombin and renal function. The main production pathways of indium-111 isotope are 112Cd(p, 2n), inCd(p, n), natCd(p, xn), 110Cd(d, n) and 109Ag(a, 2n), etc., 5 200848371 One way to obtain a maximum yield of luIn using a high abundance 112Cd (970/〇) solid target at a suitable target thickness (~ΙΟΟμηι) and proton beam energy 22 MeV). In the nuclear medicine and pharmaceutical center, the nuclear medicine oktoprost (Indium-111) was produced in a cyclotron. In China, it is impossible to produce similar isotopes, and the annual production of nuclear medicine Okpitonium (Indium-1U) is required. Cadmium-112 isotope, ', need to rely on imports, and access is not easy. Therefore, the general practitioners cannot meet the needs of the user in actual use. SUMMARY OF THE INVENTION The main object of the present invention is to provide a method for recovering cadmium-112 isotope which can save raw material cost = reduce cost, and has high recovery rate, and obtain cadmium-112 isotope with high purity. In order to achieve the above object, the present invention provides a method for recovering cadmium-112 isotope by adding a sulphide solution to a residual solution of a cadmium-112 target plating solution to produce a cadmium sulfide precipitate, and then utilizing The cadmium sulfide precipitate is dissolved by a hydrochloric acid to form a cadmium sulfide solution, and then mixed with a hydroxide solution to produce a cadmium hydroxide precipitate. Finally, the cadmium hydroxide precipitate is filtered and rinsed to recover the cadmium-112 isotope. In addition, the present invention may also firstly mix a cadmium-112 target chemical separation liquid with a cadmium bromide solution to form a mixed solution, and then add a hydroxide solution to the mixed solution and mix and stir to produce a cadmium hydroxide precipitate. Finally, the cadmium hydroxide precipitate was filtered and rinsed to recover the 200848371 • 112 isotope. [Embodiment] Please refer to the "1st and 2nd drawings" for a flow chart of a first embodiment of the present invention and a schematic flow chart of a second embodiment of the present invention. As shown in the figure: the present invention is a method for recovering cadmium "12 isotope" from the residual liquid of the 112 (4) (four) liquid or the chemical separation liquid of the dry material of 112 dry material, which is used to recover the wrong _112 isotope. The method for recovering the residual liquid of the liquid comprises at least the following steps: Step (A 1 ) Producing a cadmium sulfide sulphide material workmanship · Adding a sulphide solution to a residual solution of a cadmium _112 target plating solution to produce a vulcanization Recording (4) 'wherein, the sulfide solution can be a sodium sulfide solution, ... π step (B 1 ) to form an air money solution} 2: The sulfide precipitate is dissolved in monohydrochloric acid to form a vaporized cadmium solution. C 1 ) generating argon oxychloride precipitates 3: mixing the gas=cadmium solution into a monolithic oxide solution to produce a cadmium hydroxide precipitate, wherein the hexa hydroxide solution can be a hydrolytic solution or a hydroxide Sodium solution. Step (D 1 ) recovery of cadmium_112 isotope 4: The hydroxide ore deposit is transferred to a semi-automatic vacuum filtration system for transition and rinsing to recover the cadmium-112 isotope. _112 |& The method for recovering the separation liquid comprises at least the following steps: 200848371 Step (A 2 ) forming a mixed liquid 2 1 : mixing a cadmium-112 target chemical separation liquid with a cadmium bromide solution to form a mixed liquid. Step (B 2 Producing a cadmium hydroxide precipitate 2 2 ··taking a hydroxide solution and adding to the above mixture and stirring to produce a cadmium hydroxide precipitate, wherein the hydroxide solution may be a potassium hydroxide solution or It is a sodium hydroxide solution. Step (C 2 ) forms a cadmium-112 isotope 2 3 : The cadmium hydroxide sump material is transferred into a semi-automatic vacuum filtration system, and subjected to hydrazine and "washing" to recover the ore j-112 isotope. The ore-112 isotope recovered from the above two methods can be calcined into a solid oxidized ore, or dissolved in a cyanide solution and an assay solution to form a cadmium-112 target plating solution, and the cadmium-112 isotope recovery The rate can reach above 98%, the purity can reach about 99%, and it is easy to store. In summary, the method for recovering cadmium-112 isotope of the present invention is to recycle and recycle cadmium-112 isotope to recover the recovery rate and 98% purity In addition, it can also save the cost of purchasing raw materials and reduce the cost of nuclear medicine, so that the invention can be made more progressive, more practical, and more suitable for users. It has indeed met the requirements of the invention patent application. It is only the preferred embodiment of the present invention, and the scope of the present invention is not limited thereto; therefore, the simple equivalent changes and modifications made in accordance with the scope of the invention and the description of the invention should still be It is within the scope of the present invention. 200848371 BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is a schematic flow chart of a first embodiment of the present invention. Fig. 2 is a flow chart showing a second embodiment of the present invention. [Main component symbol description] Step (A 1 )~(D 1 ) 1 1~1 4 Step (A2)~(C2)21~23

Claims (1)

200848371 十、申請專利範圍: 1 · 一種回收鑛-112同位素之方法,其回收方法係包 含: (A 1 )將一硫化物溶液加入一録— 112 1^材電 鑛液之剩液中產生一硫化鎘沉澱物; (B 1 )將該硫化録沉澱物加入一鹽酸溶解以 形成一氣化鎘溶液; (C 1 )將該氣化鎘溶液加入一氫氧化物溶液 混合產生一氫氧化鎘沉澱物;以及 (D 1 )將該氫氧化鎘沉澱物進行過濾及漂 洗,以回收錢-112同位素。 2依據中Μ專利範圍第1項所述之回收鎘.112同位 素之方法,其中,該硫化物溶液係可為硫化鈉溶液。 3依據申請專利範圍第1項所述之回收鑛-112同位 =之方法,其中,該氫氧化物溶液係可為氫氧化鈉 溶液或氫氧化鉀溶液。 4 · 依據申請專利範圍第1項所述之回收鎘-112 素之方法,其中,該回收之鎘_112同位素係可 鍛燒形成一固態氧化鎘。 同位 藉由 ^據申4專利範圍第!項所述之回收锡·ιΐ2同位 ’、之方法,其中,該回收之鎘-112同位素係,可藉 200848371 由氰化物溶液與鹼性溶液溶解以形成一鎘_丨丨2靶 材電鍛液。 6 · —種回收鎘-112同位素之方法,其回收方法係包 含·· (A 2 )將一鎘-112靶材化學分離液與一溴化 録溶液混合形成一混合液; (B 2 )將風氧化物溶液加入該混合液中混 合授拌’產生一氫氧化鎘沉澱物;以及 (C 2 )將該氫氧化鎘沉澱物進行過濾及漂 洗,以回收鎘-112同位素。 丁 7 .依據申請專利範圍第6項所述之回收鑛_112同位 素之方法,其中,該氫氧化物溶液係可為氫氧化鈉 溶液或氫氧化鉀溶液。 8 ·依據申請專利範圍第6項所述之回收IU2同位 素之方法,其中,該回收之鎘_112同位素係可藉由 锻燒形成一固態氧化鎘。 9依據申請專利範圍第6項所述之回收鑛叩同位 素之方法’其中,該回收之鎘_112同位 氛化物溶液與驗性溶液溶解形成一錦 = 鍍液。 电200848371 X. Patent application scope: 1 · A method for recovering ore-112 isotope, the recovery method includes: (A 1 ) adding a sulfide solution to a record - 112 1 ^ material electro-mineral liquid remaining in the liquid a cadmium sulfide precipitate; (B 1 ) the sulfide precipitate is dissolved in monohydrochloric acid to form a cadmium vapor solution; (C 1 ) the cadmium vapor solution is added to a hydroxide solution to produce a cadmium hydroxide precipitate And (D 1 ) filtering and rinsing the cadmium hydroxide precipitate to recover the money-112 isotope. (2) The method for recovering cadmium.112 isotope according to the first paragraph of the Chinese Patent No. 1, wherein the sulfide solution is a sodium sulfide solution. 3 The method according to claim 1, wherein the hydroxide solution is a sodium hydroxide solution or a potassium hydroxide solution. 4 · A method for recovering cadmium-112 as described in claim 1 wherein the recovered cadmium-112 isotope is calcined to form a solid cadmium oxide. Same position by ^ According to the application of the 4 patent scope! The method for recovering tin·ιΐ2 in situ according to the item, wherein the recovered cadmium-112 isotope system can be dissolved by a cyanide solution and an alkaline solution by using 200848371 to form a cadmium_丨丨2 target electric forging liquid. . 6 · A method for recovering cadmium-112 isotope, the recovery method comprises: (A 2 ) mixing a cadmium-112 target chemical separation liquid with a bromination recording solution to form a mixed solution; (B 2 ) A wind oxide solution is added to the mixture to mix and mix to produce a cadmium hydroxide precipitate; and (C 2 ) the cadmium hydroxide precipitate is filtered and rinsed to recover the cadmium-112 isotope. A method of recovering ore_112 isotopes according to claim 6 wherein the hydroxide solution is a sodium hydroxide solution or a potassium hydroxide solution. 8. The method of recovering IU2 isotopes according to claim 6 of the patent application, wherein the recovered cadmium-112 isotope is formed by calcination to form a solid cadmium oxide. 9 A method for recovering ore isotopes according to claim 6 of the patent application scope wherein the recovered cadmium-112 ortho-saturated solution dissolves with the test solution to form a plating solution. Electricity
TW96121583A 2007-06-14 2007-06-14 Method of recovering Cd-112 isotope TW200848371A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW96121583A TW200848371A (en) 2007-06-14 2007-06-14 Method of recovering Cd-112 isotope

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW96121583A TW200848371A (en) 2007-06-14 2007-06-14 Method of recovering Cd-112 isotope

Publications (2)

Publication Number Publication Date
TW200848371A true TW200848371A (en) 2008-12-16
TWI342867B TWI342867B (en) 2011-06-01

Family

ID=44823823

Family Applications (1)

Application Number Title Priority Date Filing Date
TW96121583A TW200848371A (en) 2007-06-14 2007-06-14 Method of recovering Cd-112 isotope

Country Status (1)

Country Link
TW (1) TW200848371A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI426051B (en) * 2011-10-27 2014-02-11 Atomic Energy Council Method of fabricating radioactive isotope of indium-111

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI426051B (en) * 2011-10-27 2014-02-11 Atomic Energy Council Method of fabricating radioactive isotope of indium-111

Also Published As

Publication number Publication date
TWI342867B (en) 2011-06-01

Similar Documents

Publication Publication Date Title
von Schulthess et al. Integrated PET/CT: current applications and future directions
Dunphy et al. In vivo PET assay of tumor glutamine flux and metabolism: in-human trial of 18F-(2 S, 4 R)-4-fluoroglutamine
Öberg et al. Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours
Comoretto et al. Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT
Niccoli Asabella et al. [Retracted] The Copper Radioisotopes: A Systematic Review with Special Interest to 64 Cu
US6638490B2 (en) Production of high specific activity copper-67
CN105750538A (en) Processes, systems, and apparatus for cyclotron production of technetium-99m
Follacchio et al. Radiopharmaceuticals labelled with copper radionuclides: clinical results in human beings
Brugarolas et al. Fifty years of radiopharmaceuticals
Choiński et al. Prospects for the production of radioisotopes and radiobioconjugates for theranostics
CN106146472A (en) A kind of A Lishatan compound of double action
CN106415734A (en) Production of 43Sc radionuclide and radiopharmaceuticals thereof for use in positron emission tomography
TW200848371A (en) Method of recovering Cd-112 isotope
Piccardo et al. Role of 64CuCl2 PET/CT in detecting and staging Muscle-Invasive bladder cancer: comparison with Contrast-Enhanced CT and 18F-FDG PET/CT
Hall et al. PET imaging in differentiated thyroid cancer: where does it fit and how do we use it?
JP4792431B2 (en) Cadmium-112 isotope recovery method
Türler Matched pair theranostics: Medicinal Chemistry and Chemical Biology highlights
US8043584B2 (en) Method of recycling Cd-112 isotope
EP2014778A2 (en) Method of recycling Cd-112 isotope
Grammaticos Pioneers of nuclear medicine, Madame Curie.
CN113861254A (en) A kind of tumor PET imaging agent 68Ga-NOTA-ADG and its preparation method and application
Xiaoxiang et al. 68Ga-DOTATATE and 18F-FDG PET/CT dual-modality imaging enhances precision of staging and treatment decision for gastroenteropancreatic neuroendocrine neoplasms
TW200800372A (en) Process for producing radioisotope Tl-201
CN118155901A (en) A method for preparing high specific activity 51Cr radionuclide
CN113372399A (en) A kind of fluorine [ 2 ]18F]Synthesis method of deoxyglucose injection

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees